Neo Adjuvant Chemotherapy in Operable Breast Cancer - A Single Centre Study.

Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2015;65(2):87-108.             

De Lena M, Zucali R, Viganotti G, et al. Combined chemotherapy-radiotherapy approach in locally advanced (T 3b-T 4) breast cancer. Cancer Chemotherapy and Pharmacology 1978;1(1):53-9.           

Fisher B, Saffer E, Rudock C, et al. Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice. Cancer Res 1989;49(8):2002-4.           

Bear HD, Anderson S, Smith RE, et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2006;24(13):2019-27.

Buchholz TA, Lehman CD, Harris JR, et al. Statement of the scienceconcerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol 2008;26(5):791-7.            

Chang HR, Glaspy J, Allison MA, et al. Differential response of triple negative breast cancer to a docetaxel and carboplatin based neoadjuvant treatment. Cancer 2010;116(18):4227-37.                                 

Vasudevan DP. Jayalakshmy S, Kumar S, et al. Assessment of pathological response of breast carcinoma in modified radical mastectomy specimens after neoadjuvant chemotherapy. Article ID 536145, International Journal of Breast Cancer 2015;2015:8.       

Kuerer HM, Newman LA, Smith TL, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 1999;17(2):460-9.           

Ezzat AA, Ibrahim EM, Ajarim DS, et al. Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients. Br J Cancer 2004;90(5):968-74.            

Elston CW, Ellis IO. Classification of malignant breast disease. In: Elston CW, Ellis IO, eds. The Breast: systemic pathology. 3rd edn. Edinburgh, Scotland: Churchill Livingstone 1998: p. 239-47.

Von Minckwitz G, Untch M, Jens-Uwe B, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012;30(15):1796-804.            

Galal AE, Iman I, Abdelaziz B. Response of locally advanced breast cancer to primary chemotherapy. Egyptian Journal of Surgery 2007;26(3).